With Robert Church, Isabel Dunst, Elizabeth Halpern, Stuart Langbein, Beth Roberts
On September 17, 2010, the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA) issued a notice describing a new, voluntary parallel review process under consideration by these agencies for medical products.